Citadel Advisors’s Hinge Health HNGE Stock Holding History

Citadel Advisors’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2M	Buy	183,300 +159,400	+667%	+$8.65M	﹤0.01%	2942
2026 Q1	$922K	Buy	+23,900	New	+$993K	﹤0.01%	7849
2025 Q4	–	Sell	-54,500	Closed	-$2.67M	–	14616
2025 Q3	$2.67M	Sell	54,500 -220,900	-80%	-$11.6M	﹤0.01%	5509
2025 Q2	$14.3M	Buy	+275,400	New	+$11.1M	﹤0.01%	2580

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors's HNGE Position: Q2 2026 in Review

Citadel Advisors reduced its Hinge Health (HNGE) stake by 30% in Q2 2026, selling an estimated $17.7M and leaving 758,110 shares worth $62.9M. The position accounts for 0.01% of the portfolio, ranked #1347.

Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

Citadel Advisors held 758,110 shares of Hinge Health worth $62.9M as of Q2 2026.
Citadel Advisors sold 325,605 Hinge Health shares in Q2 2026, an estimated $17.7M.
Hinge Health made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1347 holding.
Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.